ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,098Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 1000

$1.25M Total Retail Price of All Prescriptions

Rank: 25 out of 1000

691 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 691 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

25% of this provider’s 691 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

2% of this provider’s 19,821 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
LEVOTHYROXINE SODIUM 938 827 1 4
OMEPRAZOLE 799 678 2 2
HYDROCODONE-ACETAMINOPHEN 742 521 S3 3 1
SIMVASTATIN 719 562 4 3
LISINOPRIL 618 513 5 5
CARVEDILOL 591 509 6 15
FUROSEMIDE 531 472 7 7
WARFARIN SODIUM 499 478 8 22
AMLODIPINE BESYLATE 456 419 9 6
CITALOPRAM HBR 406 313 10 17
RISPERIDONE 388 306 11 87
TRAZODONE HCL 382 276 12 29
DONEPEZIL HCL 380 359 13 32
NAMENDA 337 311 14 43
GABAPENTIN 335 260 15 11
METFORMIN HCL 328 240 16 8
METOPROLOL TARTRATE 294 232 17 19
MELOXICAM 294 230 17 14
ZOLPIDEM TARTRATE 283 171 19 16
PANTOPRAZOLE SODIUM 280 210 20 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 279 184 21 20
PRAVASTATIN SODIUM 277 263 22 12
MIRTAZAPINE 263 234 23 56
SERTRALINE HCL 255 200 24 26
TRAMADOL HCL 248 208 25 13
FLUTICASONE PROPIONATE 233 192 26 40
POTASSIUM CHLORIDE 228 192 27 10
LEVETIRACETAM 201 148 28 128
GLIMEPIRIDE 192 158 29 34
ATENOLOL 192 156 29 24
QUETIAPINE FUMARATE 179 166 31 75
ESCITALOPRAM OXALATE 178 141 32 60
ATORVASTATIN CALCIUM 175 163 33 18
DIGOXIN 167 154 34 52
HYDROCHLOROTHIAZIDE 166 134 35 9
MEGESTROL ACETATE 162 150 R 36 134
AZITHROMYCIN 161 121 37 36
METOPROLOL SUCCINATE 160 148 38 21
DIVALPROEX SODIUM 159 114 39 113
TAMSULOSIN HCL 159 130 39 33
CYMBALTA 151 103 41 53
CLOPIDOGREL 151 119 41 35
ALENDRONATE SODIUM 147 127 43 57
ALBUTEROL SULFATE 147 136 43 142
FLUOXETINE HCL 136 58 45 51
METOCLOPRAMIDE HCL 135 53 46 99
CARBIDOPA-LEVODOPA 134 120 47 116
IPRATROPIUM BROMIDE 132 123 48 203
METHYLPREDNISOLONE 131 91 49 103
OXYBUTYNIN CHLORIDE 130 81 50 145
LANTUS 127 121 51 68
BUSPIRONE HCL 124 93 52 110
PHENYTOIN SODIUM EXTENDED 121 68 53 115
NOVOLOG 116 98 54 156
NEXIUM 116 82 54 23
KLOR-CON M20 115 100 56 66
CLONIDINE HCL 115 107 56 27
FENTANYL 114 89 S2 58 100
HYDRALAZINE HCL 111 92 59 74
SANTYL 102 82 60 249
ADVAIR DISKUS 101 71 61 65
AMOX TR-POTASSIUM CLAVULANATE 100 71 62 125
PROMETHAZINE HCL 99 41 R 63 54
VESICARE 99 72 63 200
BACLOFEN 97 38 65 129
DILTIAZEM 24HR CD 93 79 66 136
PLAVIX 92 72 67 49
LOSARTAN-HYDROCHLOROTHIAZIDE 91 79 68 38
SEROQUEL 90 90 69 157
SULFAMETHOXAZOLE-TRIMETHOPRIM 88 60 70 70
PROAIR HFA 87 76 71 50
CIPROFLOXACIN HCL 86 63 72 46
NYSTATIN 86 70 72 182
JANUVIA 85 76 74 85
NITROFURANTOIN MONO-MACRO 85 69 74 191
LEVOFLOXACIN 85 68 74 73
SUCRALFATE 85 78 74 144
TOPIRAMATE 79 11 78 181
OXYCODONE HCL-ACETAMINOPHEN 79 16 S2 78 138
LOVASTATIN 76 76 80 41
PAROXETINE HCL 76 36 80 63
BENAZEPRIL HCL 75 70 82 61
LIDODERM 74 65 83 220
MUPIROCIN 73 59 84 140
HUMALOG 73 66 84 192
ALLOPURINOL 72 72 86 31
ROPINIROLE HCL 71 64 87 82
TRAMADOL HCL-ACETAMINOPHEN 70 64 88 151
LOSARTAN POTASSIUM 68 55 89 25
CEFDINIR 67 40 90 122
DILTIAZEM 24HR ER 67 55 90 189
KETOCONAZOLE 66 53 92 219
BUMETANIDE 66 64 92 112
ENOXAPARIN SODIUM 64 53 94 308
TRIAMCINOLONE ACETONIDE 63 50 95 159
SINGULAIR 62 36 96 84
LYRICA 62 23 96 47
TIZANIDINE HCL 62 12 96 76
DIOVAN 61 50 99 67
LEVEMIR 60 40 100 179
ENALAPRIL MALEATE 60 58 100 58
SPIRONOLACTONE 59 59 102 78
FLUCONAZOLE 57 36 103 102
BENZTROPINE MESYLATE 56 40 R 104 180
OXYBUTYNIN CHLORIDE ER 56 55 104 157
PREDNISONE 55 49 106 42
METHOCARBAMOL 55 27 R 106 79
RAMIPRIL 53 53 108 77
ISOSORBIDE MONONITRATE ER 53 43 108 71
OXYCODONE-ACETAMINOPHEN 52 20 S2 110 202
FAMOTIDINE 52 41 110 88
VENTOLIN HFA 51 39 112 83
DILTIAZEM HCL 51 51 112 230
DIVALPROEX SODIUM ER 50 21 114 184
PROPRANOLOL HCL 50 46 114 135
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 6, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.